Analysis
Implications of large biodata for bioeconomy
May 2024
Medical artificial intelligence, which depends on major biological data benchmarks, can improve public health and contribute to increasing global bioeconomy. Countries that strategically favor medical AI could benefit from a competitive advantage and establish global standards. This report examines the objectives indicated by China for medical AI, noting that the country’s strategy for the collection of biodata and the development of medical AI positions it as an economic and technological leader in this sector.